Cargando…

Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis

Hepatic fibrosis (HF) is a typical consequence in the development of multiple chronic liver diseases, which is intimately related to the composition and metabolic status of gut microbiota. A myriad of evidence has indicated that traditional Chinese medicine can treat HF by regulating gut microbiota....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yumeng, Zhao, Min, Jiang, Xue, Qiao, Qiaoyu, Liu, Tingting, Zhao, Chunjie, Wang, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353151/
https://www.ncbi.nlm.nih.gov/pubmed/34385924
http://dx.doi.org/10.3389/fphar.2021.713197
_version_ 1783736343276290048
author Zhang, Yumeng
Zhao, Min
Jiang, Xue
Qiao, Qiaoyu
Liu, Tingting
Zhao, Chunjie
Wang, Miao
author_facet Zhang, Yumeng
Zhao, Min
Jiang, Xue
Qiao, Qiaoyu
Liu, Tingting
Zhao, Chunjie
Wang, Miao
author_sort Zhang, Yumeng
collection PubMed
description Hepatic fibrosis (HF) is a typical consequence in the development of multiple chronic liver diseases, which is intimately related to the composition and metabolic status of gut microbiota. A myriad of evidence has indicated that traditional Chinese medicine can treat HF by regulating gut microbiota. Yinchen Wuling powder (YCWLP) is a famous traditional Chinese medicine prescription, which has been used to relieve liver diseases for thousands of years. YCWLP has demonstrated protective function on HF, but its effect on the alterations of gut microbiota is still unclear, and its explicit therapeutic mechanism also needs to be further elucidated. In this study, 16S rRNA gene sequencing and fecal metabolomics analysis were combined to investigate the influence of YCWLP on gut microbiota in HF rats and the interactions between gut microbiota and host metabolism. The results showed that YCWLP treatment significantly improved the disorder of multiple organ indices, HF-related cytokines and plasma LPS induced by HF. Masson’s trichrome stainings also showed that YCWLP treatment could significantly alleviate the severity of HF in rats. Additionally, YCWLP could reverse the significant changes in the abundance of certain genera closely related to HF phenotype, including Barnesiella [Ruminococcus] and Christensenella. Meanwhile, YCWLP significantly increased the abundance of Bifidobacterium, Coprococcus and Anaerostipes, which are closely related to butyrate production. Metabolomics and Spearman’s correlation analysis showed that YCWLP could regulate the disorder of arginine biosynthesis, sphingolipid metabolism and alanine, aspartate and glutamate metabolism in HF rats, and these regulations were intimately related to Barnesiella, [Ruminococcus], Christensenella, Coprococcus and Anaerostipes. By explaining the biological significance of the above results, we concluded that YCWLP might ameliorate HF by regulating the imbalance of gut microbiota, increasing the abundance of butyrate-producing bacteria to reduce ammonia production, promote ammonia degradation, and regulate pro-inflammatory cytokines and immune function.
format Online
Article
Text
id pubmed-8353151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83531512021-08-11 Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis Zhang, Yumeng Zhao, Min Jiang, Xue Qiao, Qiaoyu Liu, Tingting Zhao, Chunjie Wang, Miao Front Pharmacol Pharmacology Hepatic fibrosis (HF) is a typical consequence in the development of multiple chronic liver diseases, which is intimately related to the composition and metabolic status of gut microbiota. A myriad of evidence has indicated that traditional Chinese medicine can treat HF by regulating gut microbiota. Yinchen Wuling powder (YCWLP) is a famous traditional Chinese medicine prescription, which has been used to relieve liver diseases for thousands of years. YCWLP has demonstrated protective function on HF, but its effect on the alterations of gut microbiota is still unclear, and its explicit therapeutic mechanism also needs to be further elucidated. In this study, 16S rRNA gene sequencing and fecal metabolomics analysis were combined to investigate the influence of YCWLP on gut microbiota in HF rats and the interactions between gut microbiota and host metabolism. The results showed that YCWLP treatment significantly improved the disorder of multiple organ indices, HF-related cytokines and plasma LPS induced by HF. Masson’s trichrome stainings also showed that YCWLP treatment could significantly alleviate the severity of HF in rats. Additionally, YCWLP could reverse the significant changes in the abundance of certain genera closely related to HF phenotype, including Barnesiella [Ruminococcus] and Christensenella. Meanwhile, YCWLP significantly increased the abundance of Bifidobacterium, Coprococcus and Anaerostipes, which are closely related to butyrate production. Metabolomics and Spearman’s correlation analysis showed that YCWLP could regulate the disorder of arginine biosynthesis, sphingolipid metabolism and alanine, aspartate and glutamate metabolism in HF rats, and these regulations were intimately related to Barnesiella, [Ruminococcus], Christensenella, Coprococcus and Anaerostipes. By explaining the biological significance of the above results, we concluded that YCWLP might ameliorate HF by regulating the imbalance of gut microbiota, increasing the abundance of butyrate-producing bacteria to reduce ammonia production, promote ammonia degradation, and regulate pro-inflammatory cytokines and immune function. Frontiers Media S.A. 2021-07-27 /pmc/articles/PMC8353151/ /pubmed/34385924 http://dx.doi.org/10.3389/fphar.2021.713197 Text en Copyright © 2021 Zhang, Zhao, Jiang, Qiao, Liu, Zhao and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Yumeng
Zhao, Min
Jiang, Xue
Qiao, Qiaoyu
Liu, Tingting
Zhao, Chunjie
Wang, Miao
Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title_full Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title_fullStr Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title_full_unstemmed Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title_short Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
title_sort comprehensive analysis of fecal microbiome and metabolomics in hepatic fibrosis rats reveal hepatoprotective effects of yinchen wuling powder from the host-microbial metabolic axis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353151/
https://www.ncbi.nlm.nih.gov/pubmed/34385924
http://dx.doi.org/10.3389/fphar.2021.713197
work_keys_str_mv AT zhangyumeng comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT zhaomin comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT jiangxue comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT qiaoqiaoyu comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT liutingting comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT zhaochunjie comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis
AT wangmiao comprehensiveanalysisoffecalmicrobiomeandmetabolomicsinhepaticfibrosisratsrevealhepatoprotectiveeffectsofyinchenwulingpowderfromthehostmicrobialmetabolicaxis